Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study.

Dumusc, Alexandre; Alromaih, Fahad; Perreau, Matthieu; Hügle, Thomas; Zufferey, Pascal; Dan, Diana

Dumusc, Alexandre; Alromaih, Fahad; Perreau, Matthieu; Hügle, Thomas; Zufferey, Pascal; Dan, Diana.

Affiliation

Dumusc A; Department of Rheumatology, Lausanne University Hospital, 1005, Lausanne, Switzerland. alexandre.dumusc@chuv.ch.
Alromaih F; Faculty of Biology and Medicine, University of Lausanne, 1005, Lausanne, Switzerland. alexandre.dumusc@chuv.ch.
Perreau M; Department of Rheumatology, Lausanne University Hospital, 1005, Lausanne, Switzerland.
Hügle T; Faculty of Biology and Medicine, University of Lausanne, 1005, Lausanne, Switzerland.
Zufferey P; Division of Immunology and Allergy, Lausanne University Hospital, 1005, Lausanne, Switzerland.
Dan D; Department of Rheumatology, Lausanne University Hospital, 1005, Lausanne, Switzerland.

Arthritis Res Ther ; 25(1): 91, 2023 06 01.

Article in En | MEDLINE | ID: mdl-37264414

Subject(s)

Agammaglobulinemia; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Connective Tissue Diseases; Humans; Rituximab/adverse effects; Retrospective Studies; Switzerland/epidemiology; Agammaglobulinemia/chemically induced; Agammaglobulinemia/complications; Agammaglobulinemia/drug therapy; Arthritis, Rheumatoid/drug therapy; Arthritis, Rheumatoid/complications; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy; Connective Tissue Diseases/drug therapy; Connective Tissue Diseases/complications; Antibodies; Glucocorticoids/therapeutic use; Treatment Outcome

Key words

Auto-immune diseases; Connective tissue disease; Drug retention rate; Off-label; Rheumatoid arthritis; Rituximab; Vasculitis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Connective Tissue Diseases / Agammaglobulinemia / Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Arthritis Res Ther Journal subject: REUMATOLOGIA Year: 2023 Document type: Article Affiliation country: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google